Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study on Bezafibrate for Patients with Primary Biliary Cholangitis Not Responding Well to Ursodeoxycholic Acid
FranceStudy of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
GermanyStudy on the Effects of Metformin in Patients with Cirrhosis and Portal Hypertension Already Treated with Carvedilol
FranceStudy on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2
PolandStudy on Post-Surgery Antibiotic Use for Patients with Biliary Stents Undergoing Pancreaticoduodenectomy: Piperacillin and Tazobactam Evaluation
FranceStudy on Long-Term Safety and Pregnancy Outcomes of Pariglasgene Brecaparvovec in Patients with Glycogen Storage Disease Type Ia (GSDIa)
DenmarkStudy Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma
FranceTitle: Evaluation of Gallium-68 FAPI-46 PET Imaging for Better Detection and Monitoring of Pancreatic Cancer and Bile Duct Cancer
The NetherlandsStudy of Lenvatinib for Patients with Poor-Prognosis Hepatocellular Carcinoma Undergoing Percutaneous Ablation Therapy
FranceStudy on the Safety and Effectiveness of Human Plasma Proteins and Glutathione for Patients with Decompensated Cirrhosis
ItalyStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
AustriaStudy on Indocyanine Green for Patients Undergoing Emergency Surgery for Acute Cholecystitis
SpainThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
